Evidence map›Paper›PMID 22889220›Full record

ReviewImmunological reviews2012

Amino acid catabolism: a pivotal regulator of innate and adaptive immunity.

Tracy L McGaha, Lei Huang, Henrique Lemos, Richard Metz, Mario Mautino, George C Prendergast, Andrew L Mellor

Abstract readReview
In one paragraph

Review in Immunological reviews, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 130 papers.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed
2.8field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

130 citing papers in PubMed, 194 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Iron overload in CD11cCommunications biology · 2025
    Article
  10. Article
  11. Article
  12. Sulfide regulation and catabolism in health and disease.Signal transduction and targeted therapy · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Tryptophan catabolism via the kynurenine pathway regulates infection and inflammation: from mechanisms to biomarkers and therapies.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2024
    Review
  18. Review
  19. Article
  20. Acute pancreatitis is associated with gut dysbiosis in children.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2024
    Observational

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Tracy L McGahaImmunotherapy Center, Georgia Health Sciences University, Augusta, GA 30912, USA. tmcgaha@georgiahealth.edu
Lei Huang
Henrique Lemos
Richard Metz
Mario Mautino
George C Prendergast
Andrew L Mellor
Augusta University · USNewLink Genetics (United States) · USAugusta University Health · USLankenau Institute for Medical Research · US

Funding

IDO Inhibitors for Combinatorial Cancer TherapyR01CA109542 · NCI · LANKENAU INSTITUTE FOR MEDICAL RESEARCH · PI PRENDERGAST, GEORGE C · 2005 to 2015
$2.0M
Engineering DNA nanoparticles to create immune toleranceR01AI103347 · NIAID · AUGUSTA UNIVERSITY · PI MELLOR, ANDREW LEE · 2013 to 2016
$1.5M
NCI NIH HHS R01 CA109542NIAID NIH HHS R01 AI103347
6 · The paper itself

Abstract

Enhanced amino acid catabolism is a common response to inflammation, but the immunologic significance of altered amino acid consumption remains unclear. The finding that tryptophan catabolism helped maintain fetal tolerance during pregnancy provided novel insights into the significance of amino acid metabolism in controlling immunity. Recent advances in identifying molecular pathways that enhance amino acid catabolism and downstream mechanisms that affect immune cells in response to inflammatory cues support the notion that amino acid catabolism regulates innate and adaptive immune cells in pathologic settings. Cells expressing enzymes that degrade amino acids modulate antigen-presenting cell and lymphocyte functions and reveal critical roles for amino acid- and catabolite-sensing pathways in controlling gene expression, functions, and survival of immune cells. Basal amino acid catabolism may contribute to immune homeostasis that prevents autoimmunity, whereas elevated amino acid catalytic activity may reinforce immune suppression to promote tumorigenesis and persistence of some pathogens that cause chronic infections. For these reasons, there is considerable interest in generating novel drugs that inhibit or induce amino acid consumption and target downstream molecular pathways that control immunity. In this review, we summarize recent developments and highlight novel concepts and key outstanding questions in this active research field.

Indexed as

Adaptive ImmunityImmunity, InnateAmino AcidsAnimalsHumansIndoleamine-Pyrrole 2,3,-DioxygenaseProtein Serine-Threonine KinasesSelf ToleranceTOR Serine-Threonine KinasesAmino AcidsEIF2AK4 protein, humanIndoleamine-Pyrrole 2,3,-DioxygenaseMTOR protein, humanProtein Serine-Threonine KinasesTOR Serine-Threonine Kinases

Identifiers

PMID22889220
PMCPMC4384693
OpenAlexW2006544087

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.